Skip to main content
Fig. 1 | BMC Nephrology

Fig. 1

From: Clinical outcomes associated with albuminuria in central Australia: a cohort study

Fig. 1

Baseline predictors of progression in the KHA Risk Matrix Legend: The odds of progression to yellow (3.5 – 35 mg/mmol) and to red (>35 mg/mmol) as described in the Kidney Health Australia, clinical guidelines [7] and the Central Australian Rural Practitioners Association (CARPA) Standard Treatment guidelines [11]. All models adjusted for age, gender, community and ACR at baseline. *Pvalue <0.05; **Pvalue ≤ 0.01. 95 % Confidence intervals and Pvalues are shown in Additional file 1: Table S1

Back to article page